会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • Process for diagnosis of neurodegenerative diseases
    • Verfahren zur诊断神经退行性病变Erkrankungen
    • EP2963421A1
    • 2016-01-06
    • EP14175677.5
    • 2014-07-03
    • SeNostic GmbH
    • SeNostic GmbH
    • G01N33/68
    • G01N33/6896G01N1/04G01N1/286G01N21/6428G01N2021/6439G01N2800/2828G06F19/00G06F19/10G06F19/18Y02A90/26
    • The invention provides an analytical process for analysing the presence of at least one aggregated conformation prion protein in a sample of body fluid or a sample of tissue and uses the dependency of the amplification of the aggregated conformation on the shear-force intensity applied to the native conformation prion protein, which is also dependent on the specific seed present in the admixture with native conformation prion protein, for specifically analysing for the presence of an aggregated conformation prion protein in the sample. The process of the invention contains the step of determining the content of aggregated conformation prion protein generated in admixture with the sample to be analysed using one shear-force intensity, preferably using least at two different shear-force intensities and the step of comparing data on these contents of generated prion protein having an aggregated conformation with data on the content of aggregated prion protein that is pre-determined, each at the same shear-force intensity for a mixture of the same native conformation prion protein with a reference sample as a seed.
    • 本发明提供了一种分析方法,用于分析体液或组织样品中至少一种聚集的构象朊病毒蛋白的存在,并且使用聚集构象的扩增对应用于天然的剪切力强度的依赖性 构象朊病毒蛋白也依赖于与天然构象朊病毒蛋白混合物中存在的特定种子,用于特异性分析样品中聚集的构象朊病毒蛋白的存在。 本发明的方法包括以下步骤:使用一种剪切力强度,优选使用至少两种不同的剪切力强度来确定与待分析样品混合产生的聚集构象朊病毒蛋白的含量,以及将数据进行比较 生成的朊病毒蛋白的内含物具有聚集构象,其中预先确定了聚集的朊病毒蛋白质含量的数据,每种化合物的相同剪切力强度用于相同天然构象朊病毒蛋白与参照样品作为种子的混合物 。
    • 3. 发明公开
    • PROCESS FOR DIAGNOSIS OF NEURODEGENERATIVE DISEASES
    • 神经退行性疾病的诊断过程
    • EP3164716A1
    • 2017-05-10
    • EP15742188.4
    • 2015-07-01
    • SeNostic GmbH
    • LÜHRS, Thorsten
    • G01N33/68G06F19/00
    • The invention provides an analytical process for analysing the presence of at least one aggregated conformation prion protein in a sample of body fluid or a sample of tissue and uses the dependency of the amplification of the aggregated conformation on the shear-force intensity applied to the native conformation prion protein, which is also dependent on the specific seed present in the admixture with native conformation prion protein, for specifically analysing for the presence of an aggregated conformation prion protein in the sample. The process of the invention contains the step of determining the content of aggregated conformation prion protein generated in admixture with the sample to be analysed using one shear-force intensity, preferably using least at two different shear-force intensities and the step of comparing data on these contents of generated prion protein having an aggregated conformation with data on the content of aggregated prion protein that is pre-determined, each at the same shear-force intensity for a mixture of the same native conformation prion protein with a reference sample as a seed.
    • 本发明提供了用于分析体液样品或组织样品中至少一种聚集构象朊病毒蛋白的存在的分析过程,并且使用聚集构象的扩增依赖于施加于天然材料的剪切力强度 构象朊蛋白,其也依赖于存在于与天然构象朊病毒蛋白混合物中的特定种子,用于特异性分析样品中聚集构象朊病毒蛋白的存在。 本发明的方法包括使用一个剪切力强度确定与待分析样品混合产生的聚集构象朊病毒蛋白质的含量的步骤,优选至少在两个不同剪切力强度下进行测定以及比较 所产生的朊病毒蛋白质的内容物具有聚集构象和关于预先确定的聚集的朊病毒蛋白质的含量的数据,每种情况在相同天然构象朊病毒蛋白质与作为种子的参照样品的混合物的相同剪切力强度下 。